Evidence map›Paper›PMID 32461448›Full record

ArticleIndian journal of ophthalmology2020

Use of augmented reality technology for improving visual acuity of individuals with low vision.

Sarika Gopalakrishnan, Sanjana Chouhan Suwalal, Gnanapoonkodi Bhaskaran, Rajiv Raman

Abstract read
In one paragraph

Article in Indian journal of ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. The use of augmented reality and virtual reality for visual field expansion and visual acuity improvement in low vision rehabilitation: a systematic review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. 'Such a lot of bother': Qualitative results of a home trial of a wearable electronic vision enhancement system for people with age-related macular degeneration.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025
    Trial
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sarika GopalakrishnanDepartment of Bio-Chemistry, Shanmugha Arts, Science, Technology and Research Academy (SASTRA) University, Thanjavur; Optometrist, Low Vision Care Clinic, Sankara Nethralaya, Tamil Nadu, India.
Sanjana Chouhan SuwalalMedical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Gnanapoonkodi BhaskaranMedical Research Foundation, Sankara Nethralaya, Chennai, Tamil Nadu, India.
Rajiv RamanShri Bhagwan Mahavir Vitreoretinal Services, Sankara Nethralaya, Chennai, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The objective of this study was to analyze the visual acuity improvement in patients with low vision using augmented reality device who presented to the low vision care (LVC) clinic at a tertiary eye care center. Methods: A prospective study of 100 patients with low vision who were referred to the LVC clinic between July and December 2018 was done. Demographic data and visual acuity improvement assessed using augmented reality (AR) technology paired with Samsung Gear headset were documented. Results: Out of 100 patients, 74 were male and 26 were female. The median age of the overall patients was 36 (25.5) years. In 100 patients, 21% patients were found to have central field loss (CFL), 35% patients have peripheral field loss (PFL), and 44% patients were found to have overall blurred vision (OBV). Majority of the subjects with CFL (47%) and OBV (37%) has a moderate visual impairment and in PFL group (26%), severe visual impairment was more. Cone dystrophy (9%) was found to be the major cause of CFL group, retinitis pigmentosa (22%) in the case of PFL group, and optic atrophy (10%) in the case of OBV group. The median distance visual acuity 0.9 log MAR improved to 0.2 log MAR (P < 0.0001) and median near visual acuity 0.4 log MAR improved to 0.1 log MAR with a P value of < 0.0001 using AR device. Conclusion: The use of an AR device can help patients with low vision to improve their residual vision for better visual performance.

Indexed as

Augmented RealityVision, LowAdultFemaleHumansMaleProspective StudiesTechnologyVisual AcuityAugmented realitycentral field lossLow vision careoverall blurred visionperipheral field lossSamsung Gear

Identifiers

PMID32461448
PMCPMC7508072

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.